Sageworth Trust’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
– Sell
-53
Closed -$8.92K – 366
2023
Q1
$8.92K Hold
53
– – ﹤0.01% 300
2022
Q4
$9K Hold
53
– – ﹤0.01% 211
2022
Q3
$10K Hold
53
– – ﹤0.01% 198
2022
Q2
$9K Hold
53
– – ﹤0.01% 230
2022
Q1
$10K Hold
53
– – ﹤0.01% 187
2021
Q4
$14K Sell
53
-177
-77% -$47.7K ﹤0.01% 227
2021
Q3
$66K Hold
230
– – 0.01% 154
2021
Q2
$46K Buy
+230
New +$44.6K ﹤0.01% 244

Other funds holding RGEN

Sageworth Trust's RGEN Position: Q2 2023 in Review

Sageworth Trust sold out of Repligen (RGEN) in Q2 2023, closing a stake of 53 shares — an estimated $8.92K sold.

Sageworth Trust first reported a position in RGEN in Q2 2021 and held it in 8 quarters. The position peaked at $66K in Q3 2021. 446 funds tracked by Wall St. Rank hold RGEN as of Q2 2023.

  • Sageworth Trust reported no remaining Repligen position as of Q2 2023 after selling out during the quarter.
  • Sageworth Trust sold 53 Repligen shares in Q2 2023, an estimated $8.92K.
  • Sageworth Trust first reported a position in Repligen in Q2 2021 and held it in 8 quarters.
  • Sageworth Trust's Repligen position peaked at $66K in Q3 2021.
  • 446 funds tracked by Wall St. Rank held Repligen as of Q2 2023.

Based on Sageworth Trust's 13F filing for Q2 2023, filed 26 Jul 2023.